The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC).
 
Arndt Vogel
Honoraria - Advanced Accelerator Applications/Imaging Equipment Ltd; Amgen; AstraZeneca/MedImmune; BeiGene; Boehringer Pharma GmbH; Boston Scientific; Bristol-Myers Squibb; Daichi-Sankyo; Eisai; GlaxoSmithKline; Incyte; Ipsen; Janssen; Lilly; MSD; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Sirtex Medical; Taiho Oncology; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Boehringer Pharma GmbH; BTG; Daichi-Sankyo; Eisai; Incyte; IPSEN; Lilly; Novartis; Pierre Fabre; Roche; Sirtex Medical; Taiho Oncology; Taiho Oncology; Terumo
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Lilly; MSD; Roche
 
Oliver Waidmann
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Ipsen; Merck; Novartis; Roche; Shire
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Incyte; Ipsen; Merck Serono; MSD; Novartis; Roche; SERVIER; Shire
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Incyte; Ipsen; Merck Serono; MSD; Novartis; Roche; SERVIER; Shire
Research Funding - Basilea; Else Kröner-Fresenius-Stiftung; Incyte; Ipsen; Medac; Merck Serono; MSD; Novartis
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; Gilead Sciences; Ipsen; Medac; Merck
 
Tobias Müller
No Relationships to Disclose
 
Gabriele Margareta Siegler
Honoraria - Aurikamed; Deutsche Röntgengesellschaft; Eisai; Janssen-Cilag; Roche
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag
Research Funding - Novartis (Inst); Nutricia (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Foundation Medicine; Incyte; Lilly; MSD Oncology; Novartis; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - AstraZeneca (Inst); Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe (Inst); Gemeinsamer Bundesausschuss; Incyte (Inst); Lilly (Inst)
 
Enrico N. De Toni
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Research Funding - AstraZeneca; Bayer; Bristol-Myer Squibb; Ipsen; Lilly; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Celsion; IPSEN; Roche
 
Maria A Gonzalez-Carmona
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Lilly; Roche
Research Funding - Eisai
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; SERVIER
 
Guido Hausner
No Relationships to Disclose
 
Michael Geissler
No Relationships to Disclose
 
Ludwig Fischer von Weikersthal
Speakers' Bureau - Lilly; Novartis; Pierre Fabre
 
Angelika M. R. Kestler
No Relationships to Disclose
 
Fabian Finkelmeier
Speakers' Bureau - Abbvie; Eisai; Fresenius Kabi; Ipsen; MSD
Travel, Accommodations, Expenses - Ipsen
 
Matthias Kleiß
No Relationships to Disclose
 
Jens U. Marquardt
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Ipsen; Janssen; Merz GmbH; MSD Oncology; Roche
Research Funding - Bayer (Inst); Leap Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Ipsen; Merz GmbH
 
Andreas Teufel
Honoraria - Abbvie; Bayer; Eisai; Falk Pharma; Gilead Sciences; Intercept Pharmaceuticals; Ipsen; Lilly; Novartis; Roche; Sanofi
Consulting or Advisory Role - Abbvie; Bayer; Eisai; Gilead Sciences; Intercept Pharmaceuticals; Ipsen; Lilly; Novartis; Roche; Sanofi
Research Funding - Gilead Sciences; Ipsen
 
Jorge Klagges
No Relationships to Disclose
 
Regina Eickhoff
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Immutep; Institut für Klinische Krebsforschung GmbH
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Lilly; MacroGenics; Merck Sharp & Dohme
Speakers' Bureau - AIO gGmbH; Bristol-Myers Squibb; Lilly; MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Immutep; Ipsen; Lilly; Medac; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma
 
Anna Lena Saborowski
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; Roche; SERVIER
Consulting or Advisory Role - Eisai
Travel, Accommodations, Expenses - SERVIER